Robuta

https://pmc.ncbi.nlm.nih.gov/articles/PMC11784551/ Long-Term Efficacy and Safety of Open-Label Seladelpar Treatment in Patients With Primary Biliary... https://pubmed.ncbi.nlm.nih.gov/38908486/ Seladelpar as an Alternate Second-Line Agent for Primary Biliary Cirrhosis Seladelpar as an Alternate Second-Line Agent for Primary Biliary Cirrhosis second line for primary seladelpar alternate https://eprints.ncl.ac.uk/287237 Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis... https://op.europa.eu/en/web/public-procurement/procurement-details/-/procurement/804dcf60-4c89-45c6-86a4-efd92513125d Medicinal products for the digestive tract and metabolism - Seladelpar I. - EU tenders -... the digestive tract medicinal products